AGP Picks
View all

Today's News: Middle East
Provided by AGP

Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on June 15, 2026

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit
Jun. 15, 2026

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Indeterminate GlobeNewswire
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
Jun. 15, 2026

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

Indeterminate GlobeNewswire
Sparrow Pharmaceuticals Announces Interim CAPTAIN-T2D Data Validating High Prevalence of Elevated Cortisol in Difficult-to-Control Type 2 Diabetes
Jun. 15, 2026

Sparrow Pharmaceuticals Announces Interim CAPTAIN-T2D Data Validating High Prevalence of Elevated Cortisol in Difficult-to-Control Type 2 Diabetes

Indeterminate GlobeNewswire
Fate Therapeutics Appoints Laura Hamill to Board of Directors
Jun. 15, 2026

Fate Therapeutics Appoints Laura Hamill to Board of Directors

Indeterminate GlobeNewswire
QTREX Quantum’s AME Technology Achieves 97% Yield Validation at One of the Largest U.S. Interconnect Manufacturers
Jun. 15, 2026

QTREX Quantum’s AME Technology Achieves 97% Yield Validation at One of the Largest U.S. Interconnect Manufacturers

Indeterminate GlobeNewswire
Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway
Jun. 15, 2026

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

Indeterminate GlobeNewswire
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
Jun. 15, 2026

AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency

Indeterminate GlobeNewswire
Checkmarx One Achieves Industry’s Highest Scanning Fidelity, Outperforming Both Legacy Tools and AI Models
Jun. 15, 2026

Checkmarx One Achieves Industry’s Highest Scanning Fidelity, Outperforming Both Legacy Tools and AI Models

Indeterminate GlobeNewswire
Aerska Strengthens Board with Appointments of Uli Stilz and Itziar Canamasas
Jun. 15, 2026

Aerska Strengthens Board with Appointments of Uli Stilz and Itziar Canamasas

Indeterminate GlobeNewswire
KFSH Highlights Provider Transformation Through Measurable Operational Impact at HLTH Europe 2026
Jun. 15, 2026

KFSH Highlights Provider Transformation Through Measurable Operational Impact at HLTH Europe 2026

Indeterminate GlobeNewswire
Porosome Therapeutics Announces Global Drug Development Partnership with the Largest Governmental R&D Organization in India
Jun. 15, 2026

Porosome Therapeutics Announces Global Drug Development Partnership with the Largest Governmental R&D Organization in India

Indeterminate GlobeNewswire
Das KFSH stellt auf der HLTH Europe 2026 die Transformation von Gesundheitsdienstleistern anhand messbarer betrieblicher Ergebnisse vor
Jun. 15, 2026

Das KFSH stellt auf der HLTH Europe 2026 die Transformation von Gesundheitsdienstleistern anhand messbarer betrieblicher Ergebnisse vor

Indeterminate GlobeNewswire
Le KFSH met en avant la transformation des prestataires grâce à un impact opérationnel mesurable au HLTH Europe 2026
Jun. 15, 2026

Le KFSH met en avant la transformation des prestataires grâce à un impact opérationnel mesurable au HLTH Europe 2026

Indeterminate GlobeNewswire
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
Jun. 15, 2026

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

Indeterminate GlobeNewswire
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
Jun. 15, 2026

Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update

Indeterminate GlobeNewswire
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
Jun. 15, 2026

Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis

Indeterminate GlobeNewswire
Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum
Jun. 15, 2026

Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum

Indeterminate GlobeNewswire
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
Jun. 15, 2026

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

Indeterminate GlobeNewswire
4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board
Jun. 15, 2026

4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board

Indeterminate GlobeNewswire
Surge Copper Announces Results of Berg Pre-Feasibility Study with After-Tax NPV8% of C$4.6 billion and 24% IRR
Jun. 15, 2026

Surge Copper Announces Results of Berg Pre-Feasibility Study with After-Tax NPV8% of C$4.6 billion and 24% IRR

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today's News: Middle East

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.